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Background—Conventional coronary artery bypass grafting performed with the use of cardiopulmonary bypass is a
well-validated treatment for patients with ischemic heart disease. Off-pump coronary artery bypass grafting (OPCAB)
has been suggested to reduce the number of perioperative complications, especially in elderly patients.
Methods and Results—In a multicenter, randomized trial, we assigned 900 patients 70 years of age to conventional
coronary artery bypass grafting or OPCAB surgery. After 30 days, a blinded end-point committee assessed whether a
combined end point of death, stroke, or myocardial infarction had occurred. At baseline and 6 months postoperatively,
self-assessed quality of life was measured with the Medical Outcomes Study Short Form-36 and EuroQol-5D
questionnaires. A 6-month follow-up of mortality was performed through the Danish National Registry. The proportion
of patients experiencing the combined end point within 30 days was 10.2% for conventional coronary artery bypass
grafting and 10.7% for OPCAB. Implied risk difference of 0.4% (with a 95% confidence interval, 3.6 to 4.4) showed
nonsignificance in a standard test for equality (P0.83) and for noninferiority with an inferiority margin of 0.5%
(P0.49). At the 6-month follow-up, mortality was 4.7% compared with 4.2% (P0.75). Both groups showed
significant improvement in self-assessed health-related quality of life.
Conclusions—Both conventional coronary artery bypass grafting and OPCAB are safe procedures that improved the
quality of life when performed in elderly patients. No major differences in intermediate-term outcomes were found.
However, the noninferiority of OPCAB with the prespecified margin could not be confirmed.
Clinical Trial Registration—URL: http://www.clinicaltrials.gov. Unique identifier: NCT00123981.
(Circulation. 2012;125:2431-2439.)
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Ischemic heart disease is a major cause of morbidity andmortality throughout the world. With an aging population,
older patients are increasingly being considered for surgical
revascularization.
Clinical Perspective on p 2439
Conventional coronary artery bypass grafting (CCABG) per-
formed on cardiopulmonary bypass is one of the most com-
monly performed procedures and a very well-established treat-
ment for ischemic heart disease. Theoretical considerations and
results from retrospective studies have suggested that postoper-
ative morbidity may be diminished when coronary artery bypass
surgery is performed without the use of cardiopulmonary bypass
(off-pump coronary artery bypass; OPCAB). Advances in sur-
gical techniques, the use of intracoronary shunts, and improve-
ments in epicardial stabilization devices have allowed surgeons
to routinely perform multivessel OPCAB.
During the last decade, several randomized, controlled
trials have addressed the clinical outcomes of CCABG and
OPCAB. Differences in postoperative atrial fibrillation, blood
transfusion, release of biochemical markers of myocardial
damage, and length of hospitalization have seemed to favor
OPCAB.1,2 On the other hand, some studies have shown that
patients receiving OPCAB have a higher risk of incomplete
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revascularization and graft failure than patients receiving
CCABG.3–6 The question of whether OPCAB prevents post-
operative cognitive dysfunction, stroke, and other organ
dysfunction remains controversial.1–10 The recent Randomized
On/Off Bypass (ROOBY) trial comprising 2203 mainly
younger patients showed better long-term outcome of
CCABG than of OPCAB.6 Studies comparing self-assessed symp-
toms and quality of life (QoL) in younger patients have failed to
show a significant benefit of 1 method over another.11–14
Age is an independent predictor of major complications
after cardiac surgery. Several authors have claimed that the
benefits of OPCAB are more pronounced in elderly patients
and patients with high comorbidity.15–20 In the previous trials,
high-risk groups, eg, elderly patients and patients with mul-
tiple vessel disease, are underrepresented. Therefore, our aim
was to perform a large-scale randomized controlled trial to
compare the outcomes of CCABG and OPCAB in patients
70 years of age. Because CCABG is very well described
and validated in previous literature, we aimed to assess the
noninferiority of OPCAB relative to CCABG.
Methods
Design and Participants
Details of the design of the Danish On-Pump Versus Off-Pump
Randomization Study (DOORS) study have been given elsewhere.21
The study, designed as an open, randomized, controlled trial with
blinded end-point assessment, included patients from Department of
Cardiothoracic Surgery, Odense University Hospital; Department. of
Cardiac Surgery, Gentofte Hospital; Department of Cardiothoracic
Surgery, Aalborg Hospital, Aarhus University Hospital; and Depart-
ment of Cardiothoracic and Vascular Surgery, Skejby Hospital,
Aarhus University Hospital. The study was designed by the primary
investigators. Patients 70 years of age who were admitted for
nonemergent surgical revascularization at one of the participating
centers were consecutively screened for participation in the study.
The primary combined end point was mortality, myocardial infarc-
tion, or stroke within 30 days postoperatively. Patients were ex-
cluded if they were unable to understand given information or were
reluctant to participate, had had redo cardiac surgery, were techni-
cally not feasible for both procedures, and had other logistic reasons
that made inclusion impossible. Carotid ultrasound was performed
preoperatively only in case of relevant symptoms. All participating
surgeons were consultants and experienced in CCABG and multi-
vessel OPCAB surgery. Before entering the study as a surgeon, each
consultant needed to have performed a minimal number of 25
OPCAB procedures with grafts to the circumflex marginal territory,
indicating a higher total number of OPCAB procedures.
Consent and Inclusion Procedure
The patients gave written consent after written and oral information.
The study protocol was approved by the local ethics committee.
Randomization and Masking
Online randomization was performed. Block randomization was performed
1:1 in blocks of 6 stratified by treating center. Treatment was not masked.
Interventions
Anesthesia, cardiopulmonary bypass, surgery, and postoperative care were
performed according to detailed protocols.21 All operations were performed
through a full median sternotomy, and all patients in the CCABG group
were operated with aortic cross-clamping and cardioplegic arrest. Graft
patency was assessed perioperatively via a Transit Time Flow
Meter (Medistim, Oslo, Norway). All patients were treated with
clopidogrel 75 mg/d for 3 months postoperatively except patients
treated with coumarin for other reasons. Statins and salicylic acid
were given to all patients unless specifically contraindicated.
Follow-Up
Patient characteristics and intraoperative and postoperative data were
prospectively recorded. Patients with symptoms and signs of stroke
or transient cerebral ischemia were assessed by a neurologist.
Patients suspected of stroke or transient cerebral ischemia had a
magnetic resonance diffusion scan performed immediately or a
computed tomography scan 3 to 7 days after the onset of symptoms.
ECG, creatinine kinase-MB, and troponin-T were obtained 1 day before
operation and 6 to 12 hours, 16 to 24 hours, and 4 days postoperatively.
All patients had an ECG performed 30 days postoperatively. If a patient
had been transferred to another hospital or readmitted to a hospital
during the 30 days of follow-up, files and relevant computed tomogra-
phy scans, ECGs, and biochemical tests were retrieved.
A blinded end-point committee, including 2 cardiologists, 2
neurologists, and 1 cardiac surgeon not otherwise connected to the
study, assessed the data individually. Discrepancies were solved by
conference in accordance to predefined definitions of stroke and
myocardial infarction as described earlier.21
All patients were asked to fill in a booklet containing QoL
questionnaires the day before surgery. Six months later, an identical
booklet was sent to the patients. Patients who did not respond
initially were reminded once either by mail or by telephone.
Two instruments were designed to assess QoL (Short Form-36,
Danish version,22 and EuroQol/EQ5D, Danish version23). Six-month
follow-up of survival was performed through the Danish National Registry.
Statistics
The incidence of the primary combined end point, ie, mortality,
myocardial infarction, or stroke within 30 days postoperatively, was
estimated to be 8%. This estimate was based on literature and on data
from Vestdansk Hjertedatabase, a cardiac surgical database covering
60% of all cardiac procedures in Denmark. From earlier observational
studies of elderly patients undergoing coronary revascularization,15–20
we hypothesized that this incidence could be reduced to 4% by avoiding
cardiopulmonary bypass. With a margin of 0.5% in risk difference for a
test of noninferiority of OPCAB compared with CCABG, a statistical
power of 82% could be achieved by including 900 evaluable patients. It
was expected that all patients who were randomized would be available
for evaluation. Because of the relatively low incidence of severe
complications with coronary artery bypass surgery, the statistical power
was anticipated to allow for assessment only of noninferiority rather
than superiority of OPCAB relative to CCABG.
For the primary combined end point, a 1-sided Farrington-
Manning test of noninferiority test on risk difference with a prespeci-
fied margin of 0.5% was used. For comparison of baseline charac-
teristics and secondary end points, the Student t test, Pearson 2,
Mann-Whitney rank test, or Fisher exact test were used as appropri-
ate. Ninety-five percent confidence intervals for risk differences
were calculated by use of a normal approximation with standard
errors corresponding to the observed frequencies. For consistency,
the confidence interval for the primary end point was calculated with
the Farrington-Manning approach. Comparisons of QoL data were
performed with a paired Student t test comparing preoperative values
with postoperative values within treatment groups and OPCAB
values with CCABG values both preoperatively and postoperatively.
A value of P0.05 was considered significant with the exception
of noninferiority, for which a 1-sided value of P0.025 was
considered significant (ie, noninferiority would be met). Analyses
were performed according to intention to treat with STATA (Stata-
Corp LP, College Station, TX).
Results
From January 1, 2005, to November 16, 2008, a total of 1708
patients were screened, of which 900 patients were randomly
assigned to either CCABG or OPCAB. There was no signif-
icant difference between groups with regard to age, sex, or
preoperative morbidity (Table 1).
From a total of 450 in each group, 389 (86%) of the
patients randomized to receive OPCAB and 429 (95%) of the
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patients randomized to receive CCABG were operated on
according to protocol (the Figure). A total of 13 patients
were excluded from per-protocol treatment between ran-
domization and operation. The reasons for this change in
strategy were revision of the decision to operate (n5),
withdrawal of consent (n2), logistic reasons (n5), or
death (n1). Seven of these patients were operated on,
either on-pump or off-pump, by surgeons who were not
involved in the study. Three of these 7 patients were
randomized to OPCAB but received CCABG. Fifty-seven
other operations were converted from off-pump to on-
pump intraoperatively because of hemodynamic instability
(n27) or difficulties with exposure of coronary vessels
(n30). Twelve patients had their operations converted
from CCABG to OPCAB, all because of heavily calcified
aortas. All of the above-mentioned patients were still
included in the intention-to-treat analysis.
Follow-up for evaluation of the primary end-point was
complete in all patients at 30 days and 6 months. Because of
weak or inconclusive data at the 30-day follow-up, the
end-point committee was not able to reach a conclusion with
regard to stroke in 1 patient and with regard to myocardial
infarction in 3 patients. Statistically, these 4 patients were treated
as not having suffered strokes or myocardial infarctions, respec-
tively. At the 6-month follow-up, 798 of the surviving 860
patients (93%) returned the booklet of questionnaires.
Baseline and perioperative data are given in Table 2.
Patients in the OPCAB group received a mean of 2.9 (1.0)
grafts compared with 3.1 (0.93) grafts in the CCABG group
Table 1. Perioperative Clinical Data
CCABG
(n450)
OPCAB
(n450) P
Age, median (range), y 75 (70–91) 75 (70–88) 0.34 (r)
Male sex, % 78 76 0.58 (P)
Left main stenosis
50%, %
48 45 0.46 (P)
1-Vessel disease, % 2 2
2-Vessel disease, % 20 17
3-Vessel disease, % 78 81 0.35 (r)
LVEF, %
50% 69 66
30% and 50% 26 29
30% 5.2 5.4 0.42 (r)
Previous MI, %
Within 90 d before
operation
28 27 0.86 (P)
Earlier than 90 d
before operation
17 17
Never 55 56 0.89 (P)
Neurological
dysfunction, %
4.5 4.7 0.89 (P)
COPD, % 9.9 9.4 0.80 (P)
PVD, % 13 14 0.45 (P)
Previous percutaneous
coronary intervention, %
13 16 0.36 (P)
Diabetes mellitus, % 18 22 0.15 (P)
Hypertension
(medicated), %
71 71 0.89 (P)
Hypercholesterolemia
(medicated), %
90 90 0.77 (P)
Atrial fibrillation, % 4.5 5.1 0.65 (P)
Smoking, %
Current 22 29
Previous 54 45
Never 24 26 0.30 (r)
Obesity (BMI 30
kg/m2), %
20 21 0.81 (P)
Hemoglobin, median
(range), mmol/L
8.4 (5.6–10.7) 8.5 (5.0–10.7) 0.67 (r)
Serum creatinine,
median
(range), mmol/L
94 (39–490) 96 (42–534) 0.67 (r)
Dyspnea, NYHA class, %
I 18 21
II 25 28
III 23 21
IV 35 30 0.08 (r)
Angina, CCS class, %
I 13 13
II 20 25
III 49 47
IV 19 16 0.13 (r)
(Continued)
Table 1. Continued
CCABG
(n450)
OPCAB
(n450) P
Unstable angina
(nitro-iv), %
2.2 2.2 0.98 (P)
EuroScore, median
(range)
Additive 5 (3–13) 5 (3–14) 0.72 (r)
Logistic, % 4.1 (1.7–29.4) 3.9 (1.7–32.8) 0.93 (r)
Medication, %
Aspirin 93 95 0.38 (P)
-blockers 75 76 0.57 (P)
ACE inhibitors 45 45 0.91 (P)
Calcium antagonists 37 32 0.12 (P)
Nitrates 45 48 0.52 (P)
Diuretics 40 44 0.20 (P)
Coumarin 14 14 0.87 (P)
Digitalis 2.9 5.4 0.07 (P)
Clopidogrel 40 35 0.15 (P)
Antiarrythmics 4.0 5.1 0.45 (P)
CCABG indicates conventional coronary artery bypass grafting; OPCAB,
off-pump coronary artery bypass grafting; LVEF, left ventricular ejection
fraction; MI, myocardial infarction; COPD, chronic obstructive pulmonary
disorder; PVD, peripheral vascular disease; BMI, body mass index; NYHA, New
York Heart Association; CCS, Canadian Cardiovascular Society; and ACE,
angiotensin-converting enzyme. Tests are the Pearson 2 (P) or Mann-Whitney
rank (r) test.
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(P0.007). Blood loss during surgery and within the first 24
postoperative hours was significantly higher among patients
in the OPCAB group despite routine use of cell saver. No
significant difference, however, was detected in the use of
blood products. There was a trend toward longer intensive care
unit stay for the CCABG patients, resulting in a significant
difference with the Mann-Whitney rank test (P0.046) despite
similar median stays (22 hours) in both groups.
The 30-day follow-up with end points assessed by the
blinded end-point committee is given in Table 3. The pro-
portion of patients experiencing a composite end point within
30 days was 10.2% for CCABG and 10.7% for OPCAB. An
implied risk difference of 0.4% (95% confidence interval,
3.6 to 4.4) showed nonsignificance in a standard test for
equality (P0.82) and for noninferiority with an inferiority
margin of 0.5% as defined in the trial protocol (P0.49).21
No statistically significant differences were observed in the
incidence of death, stroke, or myocardial infarction, although
trends were observed toward fewer strokes but more myocar-
dial infarctions in the off-pump group.
No deaths but 7 myocardial infarctions and 3 strokes
representing a total of 8 composite end points were observed
among the 60 patients converted from OPCAB to CCABG.
Twenty-seven of these patients were converted because of
hemodynamic instability. Among this group, 3 myocardial
infarctions and 1 stroke occurred. In 3 cases, the decision to
perform CCABG in a patient randomized to OPCAB was
made preoperatively because no certified surgeon was avail-
able. One of these 3 patients suffered a myocardial infarction
and died within 30 days. Among the patients converted from
CCABG to OPCAB, 1 patient suffered a stroke and 1 patient
suffered a myocardial infarction.
Among the randomized patients, 90 were 80 years of
age. Forty-one were included in the CCABG group and 49 in
the OPCAB group. In these groups, 1 patient randomized to
CCABB and 3 patients randomized to OPCAB died within 30
days (P0.62), One patient in this age group who was
randomized to CCABG suffered a stroke compared with 2
OPCAB patients (P1.00). Three patients in the CCABG
group and 9 OPCAB patients 80 years of age suffered a
myocardial infarction (P0.21). The combined end point of
death and/or stroke and/or myocardial infarction occurred in
16 octogenarian patients: 11 in the OPCAB group and 5 in the
CCABG group (P0.27).
Six months after surgery, mortality was 21 (4.7%) in the
on-pump group and 19 (4.2%) in the off-pump group
(P0.75). Thirty-day mortality and 6-month mortality among
the screened patients who did not end up participating in the
Figure. Study flow chart. CCABG indicates
conventional coronary artery bypass;
OPCAB, off-pump coronary artery bypass.
*Among the 129 patients excluded from
the study by the operating surgeon, the
reasons were “participation in other
study,” n26; “revision of the decision to
operate (eg, favoring [percutaneous coro-
nary intervention],” n15; “decision on
concomitant other cardiac surgery (valve
or maze) to be made perioperatively,”
n16; “surgeon finds that the patient is
better operated with OPCAB,” n29; “sur-
geon finds that the patient is better oper-
ated with CCABG,” n21; and other rea-
son, why the surgeon did not find the
patient suitable for participation, eg,
“patient too frail to be asked,” n22.
2434 Circulation May 22, 2012
 by guest on January 16, 2017
http://circ.ahajournals.org/
D
ow
nloaded from
 
study were 4.2% and 7.4%, respectively (P0.01 for both
periods compared with participating patients). Improvement
in self-assessed health-related QoL was demonstrated. How-
ever, no significant differences between OPCAB and
CCABG patients were demonstrated (Table 4).
Discussion
This study is the largest randomized comparison between
CCABG and OPCAB specifically focusing on elderly pa-
tients. All patients included were 70 years of age and had a
mean EuroScore 5, implying a moderate- to high-risk
population.
Previous studies have focused on either low-risk or non-
selected patients, and in all studies, elderly high-risk patients
have been underrepresented. This is especially unfortunate
because these groups have been purported to benefit the most
from avoiding cardiopulmonary bypass. The lack of a signif-
icant difference in mortality or major morbidity reported in
previous trials could theoretically be due to the few end
points reached in predominantly low-risk patients in studies
comprising relatively small numbers of younger patients. The
fact that the ROOBY trial6 showed better outcomes after 12
months in the CCABG group could theoretically have been
explained by the fact that the younger patients included in this
trial did not benefit as much from avoiding cardiopulmonary
bypass as older patients would, whereas a slightly lower
number of grafts in the OPCAB group increased postopera-
tive risk.
The mortality in the present study was lower than predicted
by EuroScore with no significant difference at either the
30-day or 6-month follow-up. Overall mortality was accept-
able compared with earlier studies although we included
patients with a higher risk.
Although there was a trend toward higher incidence of
acute myocardial infarction in the OPCAB group, this differ-
ence did not reach statistical significance. Most of the
infarctions (94%) occurred during the first twenty-four hours
after the beginning of surgery, but it is not possible from the
current data to tell whether the trend was due to the lower
number of grafts, graft occlusion, or poorer myocardial
protection in the OPCAB group. Categorizing patients as
treated instead of intention-to-treat turns the observed risk of
composite end point against CCABG (Table 5). However,
because converted patients are highly selected, no interpreta-
tion or statistical testing of these figures appears reasonable.
In nonrandomized comparisons, earlier investigators have
found an OPCAB approach to be especially beneficial in
octogenarians.17–19 In the present study, we chose to study a
broader age group and included all patients70 years of age.
This choice was made partly because of the wish to provide
evidence that would be relevant to a larger proportion of
future patients and partly because of limited availability of
patients 80 years of age. Hence, the statistical power was
not sufficient to evaluate differences in outcome for this
specific group in the present study. The post hoc analysis
described above, however, shows a trend that points more
toward a worse than toward a better outcome for octogenarian
OPCAB patients in the current setting.
The overall number of myocardial infarctions was higher
than those reported in previous trials. This difference may
have been caused by a tighter monitoring of both ECG and
biochemical markers of myocardial damage, although the
exact level of follow-up seldom was reported in earlier trials.
The definition of myocardial infarction used in the present
study also included patients with isolated release of biochem-
Table 2. Intraoperative Variables
CCABG OPCAB P
Grafts, n (%) 1383 1309
0* 5 (1.1) 1 (0.2)
1 12 (2.7) 19 (4.2)
2 100 (22) 116 (26)
3 186 (41) 208 (46)
4 147 (33) 106 (24)
Grafts, mean (SD), n 3.1 (1.0) 2.9 (0.9) 0.007 (T)
LIMA-to-LAD grafts,
n (%)
413 (93) 409 (91) 0.29 (P)
Diagonal branch of
LAD grafts, n
(patients)
144 (140) 139 (135) 0.72 (r)
RCA/PDA/LVPDA
grafts, n (patients)
333 (318) 306 (297) 0.095 (r)
Cx grafts, n
(patients)
413 (347) 392 (349) 0.24 (r)
Proximal
anastomoses on the
aorta, n (patients)
407 (323) 386 (304) 0.33 (r)
Y grafts, n (patients) 237 (112) 268 (139) 0.10 (r)
Jump grafts, n
(patients)
442 (295) 368 (253) 0.004 (r)
Use of arterial grafts
other than LIMA, n
(patients)
223 (110) 200 (116) 0.99 (r)
Cardiopulmonary
bypass time, median
(range), min
67 (24–250) 66 (27–188)
n 60
Cross-clamp time,
median (range), min
39 (10–120) 35 (0–80)
n 60
Conversions, n (%) 12 (2.6) 60 (13.3)
Inotropes, n (%) 59 (13.4) 48 (10.76) 0.23 (P)
Blood loss, median
(range), mL
1243 (220–7500) 1500 (155–8800) 0.001 (P)
Transfusion, n (%) 73 (17) 75 (17) 0.91 (P)
ICU stay, median
(range), h
22 (13–767) 22 (14–802) 0.046 (P)
Hospital stay, mean
(SD), d
8.1 (7.2) 7.6 (8.0) 0.38 (P)
CCABG indicates conventional coronary artery bypass grafting; OPCAB,
off-pump coronary artery bypass grafting; LIMA, left internal mammary
artery; LAD, left anterior descending artery; RCA, right coronary artery;
PDA, posterior descending artery; LVPDA, left ventricular posterior de-
scending artery; and ICU, intensive care unit. Tests are the Pearson 2 (P),
Mann-Whitney rank (r), or t (T) test. All values are given according to the
original intention to treat.
*Patients for whom the strategy to operate was changed before operation or
who died before operation.
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ical markers, not just patients with Q-wave infarctions as in
some of the previous studies.5 The age of the participating
patients, previously shown as independent predictors of
perioperative myocardial damage,24 was higher in this study
than in most previous studies. In addition, this study was
performed in an environment with a high proportion of
percutaneous revascularizations. During the period from 2005
to 2008, when the study was performed, only 17.6% of
coronary revascularizations in Denmark were performed
surgically.25 For comparison, 25.6% of patients admitted for
coronary revascularization in the United States in 2007
underwent surgery.26 This reality suggests that the patients
involved in the present study had advanced coronary disease
and complex coronary anatomy.
Off-pump surgery has been suggested to decrease the risk
of stroke. Although seen only as trends in earlier trials, the
difference has reached statistical significance in a recent
meta-analysis.10 However, the ROOBY trial, comprising a
high proportion of the total number of randomized patients,
showed a trend in the opposite direction.6 In the present
study, more strokes occurred in the on-pump group, although
the difference was not statistically significant (P0.12).
Clamping may have affected the risk of stroke after
OPCAB. The protocol left the use of epiaortic ultrasound,
side-biting clamp, double clamping, Heart-String device, or
no-touch aorta to the surgeon’s discretion. Although only
27% of OPCAB operations were performed with a side-biting
clamp, this group represented a substantial part of the strokes
suffered by OPCAB patients. Among the 10 patients random-
ized to OPCAB who suffered a stroke, 3 had been converted
to on-pump perioperatively, and 5 were operated on with a
side-biting clamp. One patient operated on with a Heart
String device suffered a stroke on the third postoperative day
after electroconversion of atrial fibrillation. Another patient
operated on with no-touch aorta technique suffered a stroke
28 days after surgery. No cardiac cause for this stroke was
suspected.
The proportion of on-pump patients who suffered a stroke
in the present study was 4.0%, which is higher than the 3.2%
weighted average reported in a meta-analysis of observational
studies but lower than in some of the individual studies
reported in this review.16 Procedures that might have de-
creased the stroke rate, ie, preoperative screening of high-risk
patients with carotid ultrasound and perioperative epiaortic
ultrasound, were not part of the study protocol and were
performed only at the individual surgeon’s discretion. This
may have influenced the overall stroke rate in the study. In
addition, a more meticulous follow-up performed in a pro-
spective study compared with retrospective data acquisition
may potentially have allowed a higher proportion of late
strokes and small strokes to be identified.
When comparing OPCAB and CCABG in clinical trials,
much discussion has related to surgeon experience. Excellent
results have been reported in trials with only 1 or a few highly
dedicated off-pump surgeons, whereas lower graft patency
rates are reported by others. The present study included the
results from 12 surgeons from 4 different centers, all with
intermediary experience in OPCAB (see the online-only Data
Supplement). All participating surgeons were consultants,
and as opposed to the ROOBY trial, residents were never the
primary surgeon at an operation. Before participation in the
present study, the surgeons needed to have performed 25
off-pump operations with anastomoses to the obtuse marginal
branches of the circumflex artery, usually implying a higher
number of OPCAB procedures with grafts only to the anterior
left or right ventricular wall. Nevertheless, all participating
surgeons had more experience in on-pump surgery, and a
learning curve may have influenced the results.
Study Limitations
The present study is larger than most of the previous trials,
only surpassed by the ROOBY trial.6 The statistical strength
of the study is further enhanced by the inclusion of interme-
diate and high-risk patients, who have been underrepresented
in earlier trials. Still, because of the relatively low incidence
of severe complications to coronary artery bypass surgery,
whether performed with or without the use of cardiopulmo-
nary bypass, the statistical power was anticipated to allow the
assessment only of noninferiority rather than superiority of
OPCAB relative to CCABG. This was still considered rele-
vant because CCABG is so well described and validated.
When introducing an alternative treatment like OPCAB, we
found that it would require a test of noninferiority. Still,
mainly as a result of the unexpectedly high number of
myocardial infarctions in the OPCAB group, a definite
conclusion with regard to noninferiority of OPCAB could not
be reached. Given the equality of trends, it seems unlikely
that even a much higher number of included patients would
have proven 1 treatment superior to the other in the current
setup. Although a reduction of complication rate of 50%, as
assumed in the power calculation, may seem overly optimis-
tic in retrospect, it was realistic on the basis of the results
from similar patient groups published at the time of the
planning of the present study.15–20
Patients and professionals were not blinded with regard to
treatment because this was considered impractical. Only 1
previous trial with only 1 participating center and only 1
Table 3. Events at 30 Days: Patients Categorized According to Intention to Treat
Event CCABG, n (%) OPCAB, n (%) P Risk Difference (CI), %
Death 8 (1.8) 7 (1.6) 0.80 0.22 (1.89 to 1.45)
Stroke 18 (4.0) 10 (2.2) 0.12 1.78 (4.04 to 0.49)
Myocardial infarction 25 (5.6) 37 (8.2) 0.12 2.67 (0.64 to 5.86)
Death, stroke, or myocardial infarction 46 (10.2) 48 (10.7) 0.82/0.49* 0.44 (3.55 to 4.44)*
CCABG indicates conventional coronary artery bypass grafting; OPCAB, off-pump coronary artery bypass grafting; and CI,
confidence interval. Tests are Fisher exact test illustrated by point estimates with 95% CIs.
*Per-protocol Farrington-Manning test of noninferiority with a margin of 0.5%.
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surgeon2 managed to do this. The end-point committee,
however, was blinded.
The 13% conversion rate from OPCAB to CCABG is
higher than reported in studies with only 1 or a few highly
dedicated OPCAB surgeons. It is, however, at the same level
as in the ROOBY trial, which was performed in a population
with much lower perioperative risk. This finding, together
with a mortality rate well below that predicted by EuroScore,
indicates that the safety of the procedures was acceptable.
Nevertheless, we recognize that risk-reducing strategies, in-
cluding a consequent no-touch aorta strategy, may have
limited the number of strokes in the OPCAB group. In
addition, although as described above some experience in
both techniques was required from the participating consul-
tants, the learning curve may imply that better results could
be obtained with more experience.
The present report does not include data on long-term
morbidity and mortality. However, further follow-up and
Table 4. Medical Outcomes Study Short Form-36 Domain Scores
Domain
Preoperatively
6 Months
Postoperatively P,
Preoperatively vs
Postoperatively
P, On-Pump vs
Off-Pump Preoperatively,
6 Months
PostoperativelyMean (SD) 95% CI Mean (SD) 95% CI
Physical component
Physical functioning
On-pump 59 (23) 57–61 71 (24) 69–74 0.001 0.62, 0.70
Off-pump 60 (24) 58–62 72 (25) 69–74 0.001
Role physical
On-pump 23 (35) 19–26 50 (44) 45–54 0.001 0.74, 0.62
Off-pump 24 (35) 20–27 51 (44) 46–56 0.001
Bodily pain
On-pump 60 (24) 58–62 81 (22) 79–84 0.001 0.87, 0.79
Off-pump 60 (25) 58–63 81 (23) 79–83 0.001
General health
On-pump 66 (17) 64–68 69 (20) 67–71 0.002 0.66, 0.90
Off-pump 66 (18) 65–68 69 (20) 67–71 0.023
Mental component
Vitality
On-pump 51 (23) 49–54 65 (24) 62–67 0.001 0.68, 0.52
Off-pump 52 (23) 50–54 64 (24) 61–66 0.001
Social functioning
On-pump 81 (23) 79–83 89 (20) 87–91 0.001 0.98, 0.13
Off-pump 81 (25) 78–83 86 (22) 84–89 0.001
Role emotional
On-pump 56 (44) 51–60 64 (39) 60–68 0.002 0.28, 0.95
Off-pump 59 (43) 55–63 64 (41) 60–68 0.091
Mental health
On-pump 73 (20) 71–75 82 (17) 80–84 0.001 0.10, 0.49
Off-pump 75 (19) 73–77 81 (18) 79–83 0.001
Physical component summary
On-pump 38 (9) 45 (10) 0.001 0.92, 0.88
Off-pump 38 (9) 45 (10) 0.001
Mental component summary
On-pump 50 (11) 53 (10) 0.001 0.15, 0.36
Off-pump 51 (11) 52 (10) 0.06
EuroQol summary
On-pump 0.75 (16) 0.73–0.76 0.84 (17) 0.83–0.86 0.001 0.68, 0.94
Off-pump 0.75 (0.15) 0.74–0.76 0.84 (18) 0.83–0.86 0.001
EuroQol visual
On-pump 59 (19) 57–61 73 (21) 71–75 0.001 0.24, 0.74
Off-pump 60 (20) 58–62 73 (21) 71–75 0.001
CI indicates confidence interval. Values are mean when appropriate. Statistical comparisons were performed with a paired Student t test.
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angiographic control of graft patency are planned and in the
process of being performed.
Conclusions
In conclusion, we found no major advantage in using OPCAB
in elderly patients with regard to major morbidity or self-
assessed health-related QoL, and noninferiority relative to
CCABG with regard to the primary composite end point was
not proven. Both techniques are relatively safe and can be
performed with a fairly low rate of major complications in
patients with high age and comorbidities. In the editorial
accompanying the publication of the ROOBY trial, it was
suggested that OPCAB is “… a technique reserved for
selected patients and skilled surgeon advocates.”27 Although
this is ideally true for any kind of operations, the results of the
present study do not prove OPCAB to be inferior to CCABG
when applied to a general elderly population. The short to
intermediate follow-up in the present study mainly elucidates
the comparative safety of the operations. The relative efficacy
will be dependent on graft patency and will need to be
evaluated by a longer period of follow-up.
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CLINICAL PERSPECTIVE
Conventional coronary artery bypass grafting performed with the use of cardiopulmonary bypass is a well-validated treatment
for patients with ischemic heart disease. Off-pump coronary artery bypass grafting (OPCAB) has been suggested to reduce the
number of perioperative complications, especially in elderly patients. In a multicenter, randomized trial, we assigned 900 patients
70 years of age to conventional coronary artery bypass grafting or OPCAB surgery. The primary end point was to test the
noninferiority of a composite end point of death, stroke, and myocardial infarction within 30 days postoperatively. According to
the intention-to-treat analysis, statistically nonsignificant trends toward fewer perioperative strokes (2.2% versus 4.0%; P0.12)
but more myocardial infarctions (8.2% versus 5.6%; P0.12) were seen in the OPCAB patients. The proportion of patients
experiencing the combined end point within 30 days was 10.2% for conventional coronary artery bypass grafting and 10.7% for
OPCAB. Hence, the noninferiority of OPCAB with the prespecified margin could not be confirmed. The mean number of grafts
performed was significantly lower in the OPCAB group (2.9 versus 3.1; P0.005). At the 6-month follow-up, mortality was
4.2% in the OPCAB group versus 4.7% in the conventional coronary artery bypass grafting group (P0.75). Both groups
showed significant improvement in self-assessed health-related quality of life after 6 months compared with preoperatively. We
conclude that both conventional coronary artery bypass grafting and OPCAB are safe procedures improving quality of life when
performed in elderly patients. No major differences in short- or intermediate-term outcomes were found.
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